Cubist Systematic Strategies’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374 | Buy |
+13
| New | +$374 | ﹤0.01% | 1451 |
|
|
2023
Q3 | – | Sell |
-47,192
| Closed | -$850K | – | 2090 |
|
|
2023
Q2 | $850K | Buy |
47,192
+46,092
| +4,190% | +$831K | 0.01% | 1224 |
|
|
2023
Q1 | $17.7K | Buy |
+1,100
| New | +$17.7K | ﹤0.01% | 2634 |
|
|
2022
Q4 | – | Sell |
-1,925
| Closed | -$38K | – | 3322 |
|
|
2022
Q3 | $38K | Sell |
1,925
-6,553
| -77% | -$129K | ﹤0.01% | 3358 |
|
|
2022
Q2 | $158K | Buy |
8,478
+3,503
| +70% | +$65.3K | ﹤0.01% | 3256 |
|
|
2022
Q1 | $109K | Buy |
4,975
+3,348
| +206% | +$73.4K | ﹤0.01% | 3190 |
|
|
2021
Q4 | $46K | Sell |
1,627
-19,311
| -92% | -$546K | ﹤0.01% | 3318 |
|
|
2021
Q3 | $441K | Buy |
20,938
+8,657
| +70% | +$182K | 0.01% | 2120 |
|
|
2021
Q2 | $231K | Buy |
12,281
+12,264
| +72,141% | +$231K | ﹤0.01% | 2467 |
|
|
2021
Q1 | $0 | Sell |
17
-1,151
| -99% | – | ﹤0.01% | 2850 |
|
|
2020
Q4 | $16K | Buy |
+1,168
| New | +$16K | ﹤0.01% | 2508 |
|
|
2020
Q3 | – | Sell |
-1,483
| Closed | -$26K | – | 2506 |
|
|
2020
Q2 | $26K | Buy |
+1,483
| New | +$26K | ﹤0.01% | 2304 |
|
|
2020
Q1 | – | Sell |
-4,700
| Closed | -$118K | – | 2208 |
|
|
2019
Q4 | $118K | Buy |
4,700
+2,922
| +164% | +$73.4K | ﹤0.01% | 2155 |
|
|
2019
Q3 | $27K | Buy |
+1,778
| New | +$27K | ﹤0.01% | 2102 |
|